Home/Filings/4/0001193125-25-327135
4//SEC Filing

Breedlove Robert Charles 4

Accession 0001193125-25-327135

CIK 0001783183other

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 5:50 PM ET

Size

5.4 KB

Accession

0001193125-25-327135

Insider Transaction Report

Form 4
Period: 2025-12-18
Breedlove Robert Charles
Principal Accounting Officer
Transactions
  • Tax Payment

    Common Stock

    2025-12-18$16.28/sh230$3,74447,844 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    6,945.4
Footnotes (1)
  • [F1]Represents shares underlying the restricted stock units that were surrendered by the reporting person to the Issuer in satisfaction of the Issuer's tax withholding obligation.

Documents

1 file

Issuer

Phathom Pharmaceuticals, Inc.

CIK 0001783183

Entity typeother

Related Parties

1
  • filerCIK 0002066645

Filing Metadata

Form type
4
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 5:50 PM ET
Size
5.4 KB